IPCA-Prochlorperazine

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Prochlorperazine maleate 5mg

Available from:

Ipca Pharma (NZ) Pty Limited

INN (International Name):

Prochlorperazine maleate 5 mg

Dosage:

5 mg

Pharmaceutical form:

Tablet

Composition:

Active: Prochlorperazine maleate 5mg Excipient: Colloidal silicon dioxide Lactose monohydrate Magnesium stearate Maize starch

Prescription type:

Prescription

Manufactured by:

Trifarma SpA

Therapeutic indications:

Prochlorperazine maleate is used in vertigo due to Meniere's syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.

Product summary:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC/Al - 250 tablets - 24 months from date of manufacture stored at or below 25°C

Authorization date:

2013-06-27